Myelofibrosis Treatment Market Trends and Growth Drivers 2026-2035
The myelofibrosis treatment market is witnessing steady growth, driven by advancements in targeted therapies and increasing awareness of hematologic malignancies. The market size is valued at USD 834.5 million in 2025 and is projected to reach USD 1,433.9 million by 2035, expanding at a CAGR of 6.2% during the forecast period (2026–2035). The rising prevalence of myeloproliferative disorders and growing adoption of novel JAK inhibitors are key factors propelling global market expansion.